The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study)

The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study)

BackgroundThe COVID-19 pandemic led to a rapid reorganization of healthcare activities, leading to reduced access to clinics, interruption of screenings, and treatment schedule modifications in several cancer types. Few data are available on sarcomas. We analyzed COVID-19-related diagnostic delay in...

Full description

Bibliographic Details
Main Authors: Concetta Elisa Onesti, Sabrina Vari, Francesca Nardozza, Gabriella Maggi, Denise Minghelli, Barbara Rossi, Francesca Sperati, Elisa Checcucci, Wioletta Faltyn, Maria Cecilia Cercato, Antonella Cosimati, Roberto Biagini, Gennaro Ciliberto, Virginia Ferraresi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
COVID-19
pandemic
soft tissue sarcoma
bone sarcoma
aggressive benign musculoskeletal diseases
diagnostic delay
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1000056/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1000056/full

Similar Items